Handicap International launches program in Rwanda to address HIV/AIDS among blind people

Efforts to address HIV/AIDS in Rwanda have not included blind people, Jacques Sindayigaya, Handicap International's coordinator of a new program to address the virus in the population, said Monday during a workshop in Rwanda's capital of Kigali, the New Times/AllAfrica.com reports.

Participants at the workshop aimed to discuss ways to better address HIV/AIDS among blind people through the new program. Representatives from the program's five pilot districts in Rwanda's Eastern Province attended the workshop and received training on providing HIV testing to blind people. Handicap International also distributed radio receivers, cassettes and batteries to help workshop participants implement the program in the pilot districts, which include Gatsibo, Kayonza, Kirehe, Ngoma and Nyagatare.

"Programs to fight AIDS have not been considering the fact that [blind] people cannot read what is written in either books or billboards," Sindayigaya said, adding that the program "will help in finding ways of helping and incorporat[ing] them in the general program to fight HIV/AIDS among Rwandans."

Donatilla Kanimba, executive secretary of the Rwandan Union of the Blind, said the program will help blind people understand HIV/AIDS, adding that health workers sometimes "have misconceptions about the blind" and "isolate [blind people] when it comes to health issues" (Mutesi, New Times/AllAfrica.com, 5/15).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity